Phenotyping and genotyping of coagulation factor V Leiden

Thrombosis and Haemostasis

Volumn 75, Issue 2, 1996, Pages 267-269

  Engel, H ^a   Zwang, M ^a   Van Vliet, H H D M ^b   Michiels, J J ^b   Stibbe, J ^b   Lindemans, J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Department of Haematology ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5; OLIGONUCLEOTIDE;

ALLELE; ARTICLE; ASSAY; BLOOD CLOTTING FACTOR 5 DEFICIENCY; CONTROLLED STUDY; GENE MUTATION; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NUCLEIC ACID BASE SUBSTITUTION; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0029925813     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650258     Document Type: Article

References (14)

1. Zöller B, Dahlbäck B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 1994; 343: 1536-8.
2. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369; 64-7.
3. 506 of factor V. Lancet 1994; 343: 1535-6.
4. Greengard JS, Eichinger S, Griffin JH, Bauer KA. Variability of thrombosis among homozygous siblings with resistance to activated Protein C due to an Arg → Gln mutation in the gene for factor V. N Engl J Med 1994; 331. 1559-62.
5. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognised mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-8.
6. Dahlbäck B, Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci USA 1994; 91: 1396-400.
7. Sun X, Evatt B, Griffin JH. Blood coagulation factor Va abnormally associated with resistance to activated Protein C in venous thrombophilia. Blood 1994; 83: 3120-5.
8. de Ronde H, Bertina RM. Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnostic criteria. Thromb Haemost 1994; 72: 880-6.
9. Trossaërt M, Conard J, Horrellou MH, Samama MM, Ireland H, Bayston TA, Lane DA. Modified APC resistance assay for patients on oral anticoagulants. Lancet 1994; 344: 1709.
10. Kawasaki ES. Sample preparation from blood, cells, and other fluids. In. PCR Protocols, A guide to methods and Applications. Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds). San Diego, Academic Press Inc. 1990; p 146.
11. Cripe LD, Moore KD, Kane WH. Structure of the gene for human coagulation factor V. Biochemistry 1992; 31: 3777-85.
12. Jenny RJ, Pittman DD, Toole JJ, Kriz RW, Aldape RA, Hewick RM, Kaufman RJ, Maun KG. Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci USA 1987; 84: 4846-50.
13. 1-antitrypsin Z and S mutations by polymerase chain reaction-mediated site direction mutagenesis. Clin Chem 1992; 38: 1486-8.
14. Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalsheker N, Smith JC, Markham AF. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 1989; 17: 2503-16.